HomeCompareHSRMF vs PFE

HSRMF vs PFE: Dividend Comparison 2026

HSRMF yields 666.67% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HSRMF wins by $608115.61M in total portfolio value
10 years
HSRMF
HSRMF
● Live price
666.67%
Share price
$0.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$608115.66M
Annual income
$469,561,018,816.25
Full HSRMF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — HSRMF vs PFE

📍 HSRMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHSRMFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HSRMF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HSRMF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HSRMF
Annual income on $10K today (after 15% tax)
$56,666.67/yr
After 10yr DRIP, annual income (after tax)
$399,126,865,993.81/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, HSRMF beats the other by $399,126,842,864.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HSRMF + PFE for your $10,000?

HSRMF: 50%PFE: 50%
100% PFE50/50100% HSRMF
Portfolio after 10yr
$304057.85M
Annual income
$234,780,523,013.39/yr
Blended yield
77.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

HSRMF
No analyst data
Altman Z
-0.6
Piotroski
2/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HSRMF buys
0
PFE buys
0
No recent congressional trades found for HSRMF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHSRMFPFE
Forward yield666.67%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$608115.66M$51.1K
Annual income after 10y$469,561,018,816.25$27,210.54
Total dividends collected$596792.85M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HSRMF vs PFE ($10,000, DRIP)

YearHSRMF PortfolioHSRMF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$77,367$66,666.67$9,161$701.38+$68.2KHSRMF
2$564,818$482,035.31$8,610$859.79+$556.2KHSRMF
3$3,893,246$3,288,890.67$8,366$1,081.25+$3.88MHSRMF
4$25,352,760$21,186,987.16$8,483$1,405.66+$25.34MHSRMF
5$156,070,781$128,943,327.59$9,084$1,907.24+$156.06MHSRMF
6$908,837,800$741,842,064.29$10,418$2,732.78+$908.83MHSRMF
7$5,009,769,782$4,037,313,336.56$13,007$4,193.56+$5009.76MHSRMF
8$26,159,339,258$20,798,885,591.56$18,010$7,005.87+$26159.32MHSRMF
9$129,490,317,125$101,499,824,118.87$28,216$12,979.89+$129490.29MHSRMF
10$608,115,658,140$469,561,018,816.25$51,081$27,210.54+$608115.61MHSRMF

HSRMF vs PFE: Complete Analysis 2026

HSRMFStock

Hastings Technology Metals Limited engages in the exploration and development of rare earth deposits in Australia. The company focuses on neodymium and praseodymium minerals. Its flagship project is the Yangibana Rare Earths Project, which holds 100% interests in 6 mining leases, 2 prospecting licenses, 11 exploration licenses, 5 general purpose leases, and 13 miscellaneous licenses; and 70% interests in 3 mining leases, 8 exploration licenses, and 2 general purpose leases that covers an area of 650 sq km area located in the Gascoyne region of Western Australia. The company was formerly known as Hastings Rare Metals Limited and changed its name to Hastings Technology Metals Limited in October 2015. Hastings Technology Metals Limited was incorporated in 2006 and is based in Perth, Australia.

Full HSRMF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this HSRMF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HSRMF vs SCHDHSRMF vs JEPIHSRMF vs OHSRMF vs KOHSRMF vs MAINHSRMF vs JNJHSRMF vs MRKHSRMF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.